Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans
Emergent BioSolutions (NYSE: EBS) is partnering with pro football legend Emmitt Smith to raise awareness of the Ready to Rescue initiative in New Orleans during the Big Game weekend. The campaign focuses on opioid overdose prevention and the use of NARCAN® Nasal Spray.
Despite a national decline in opioid overdose deaths reported by the CDC, New Orleans continues to face increasing drug-related deaths. In 2022, drug-related overdose deaths were nearly double the number of homicides in the city. The campaign features Smith in a 'Lay, Spray, Stay' educational video demonstrating NARCAN® administration, which will be displayed on local taxi television screens throughout the city.
The initiative coincides with New Orleans hosting approximately 83,000 fans for the Big Game. Hundreds of NARCAN® Nasal Spray cartons will be distributed in the city during the weekend. The campaign aims to reduce stigma around accidental opioid poisonings and educate communities on life-saving interventions.
Emergent BioSolutions (NYSE: EBS) sta collaborando con il leggendario giocatore di football Emmitt Smith per aumentare la consapevolezza riguardo all'iniziativa Ready to Rescue a New Orleans durante il fine settimana del Big Game. La campagna si concentra sulla prevenzione delle overdose da oppioidi e sull'uso di NARCAN® Nasal Spray.
Nonostante una diminuzione nazionale delle morti per overdose da oppioidi segnalata dal CDC, New Orleans continua ad affrontare un incremento delle morti legate ai drogati. Nel 2022, le morti per overdose da droga sono state quasi il doppio rispetto al numero di omicidi nella città. La campagna presenta Smith in un video educativo 'Lay, Spray, Stay' che dimostra l'uso di NARCAN®, che sarà mostrato sugli schermi televisivi dei taxi locali in tutta la città.
L'iniziativa coincide con l'hosting di circa 83.000 fan a New Orleans per il Big Game. Centinaia di cartoni di NARCAN® Nasal Spray saranno distribuiti in città nel corso del fine settimana. La campagna mira a ridurre lo stigma attorno alle intossicazioni accidentali da oppioidi e a educare le comunità su interventi salvavita.
Emergent BioSolutions (NYSE: EBS) se está asociando con la leyenda del fútbol americano Emmitt Smith para aumentar la conciencia sobre la iniciativa Ready to Rescue en Nueva Orleans durante el fin de semana del Gran Juego. La campaña se centra en la prevención de sobredosis por opioides y el uso de NARCAN® Nasal Spray.
A pesar de la disminución nacional en las muertes por sobredosis de opioides reportadas por los CDC, Nueva Orleans sigue enfrentando un aumento en las muertes relacionadas con las drogas. En 2022, las muertes por sobredosis de drogas fueron casi el doble que el número de homicidios en la ciudad. La campaña presenta a Smith en un video educativo 'Lay, Spray, Stay' que demuestra la administración de NARCAN®, que se mostrará en las pantallas de televisión de los taxis locales en toda la ciudad.
La iniciativa coincide con la recepción de aproximadamente 83,000 fanáticos en Nueva Orleans para el Gran Juego. Cientos de cartones de NARCAN® Nasal Spray serán distribuidos en la ciudad durante el fin de semana. La campaña tiene como objetivo reducir el estigma en torno a las intoxicaciones accidentales por opioides y educar a las comunidades sobre intervenciones que salvan vidas.
Emergent BioSolutions (NYSE: EBS)는 빅 게임 주말 동안 뉴올리언스에서 Ready to Rescue 이니셔티브에 대한 인식을 높이기 위해 미식축구 전설 에미트 스미스와 협력하고 있습니다. 이 캠페인은 오피오이드 과다복용 예방과 NARCAN® Nasal Spray의 사용에 초점을 맞추고 있습니다.
CDC가 보고한 바와 같이 전 국가적으로 오피오이드 과다복용 사망자 수는 감소했지만, 뉴올리언스는 여전히 약물 관련 사망자 수가 증가하고 있습니다. 2022년에는 약물 과다복용 사망자가 이 도시의 살인 사건 수의 거의 두 배에 달합니다. 캠페인에서는 스미스가 NARCAN® 사용을 시연하는 'Lay, Spray, Stay' 교육 영상을 선보이며, 이 영상은 도시 전역의 택시 TV 화면에 방송될 예정입니다.
이 이니셔티브는 뉴올리언스에서 약 83,000명의 팬이 빅 게임을 위해 모이는 것과 동시에 진행됩니다. 주말 동안 수백 개의 NARCAN® Nasal Spray 상자가 도시에서 배포될 것입니다. 이 캠페인은 우발적인 오피오이드 중독에 대한 낙인을 줄이고, 생명을 구하는 개입에 대해 지역 사회를 교육하는 것을 목표로 하고 있습니다.
Emergent BioSolutions (NYSE: EBS) s'associe à la légende du football Emmitt Smith pour sensibiliser à l'initiative Ready to Rescue à La Nouvelle-Orléans pendant le week-end du Big Game. La campagne se concentre sur la prévention des overdoses d'opioïdes et l'utilisation de NARCAN® Nasal Spray.
Malgré une baisse nationale des décès par overdose d'opioïdes signalée par les CDC, La Nouvelle-Orléans continue de faire face à une augmentation des décès liés aux drogues. En 2022, les décès par overdose liés aux drogues étaient presque le double du nombre d'homicides dans la ville. La campagne met en avant Smith dans une vidéo éducative intitulée 'Lay, Spray, Stay' qui montre l'administration de NARCAN®, et qui sera diffusée sur les écrans de télévision des taxis locaux à travers la ville.
L'initiative coïncide avec l'accueil d'environ 83 000 fans à La Nouvelle-Orléans pour le Big Game. Des centaines de cartons de NARCAN® Nasal Spray seront distribués dans la ville pendant le week-end. La campagne vise à réduire la stigmatisation liée aux empoisonnements accidentels par opioïdes et à sensibiliser les communautés aux interventions qui sauvent des vies.
Emergent BioSolutions (NYSE: EBS) kooperiert mit der Football-Legende Emmitt Smith, um während des Big Game-Wochenendes in New Orleans auf die Initiative Ready to Rescue aufmerksam zu machen. Die Kampagne konzentriert sich auf die Prävention von Opioidüberdosierungen und die Anwendung von NARCAN® Nasal Spray.
Trotz eines nationalen Rückgangs der gemeldeten Opioidüberdosierungen durch die CDC sieht sich New Orleans weiterhin einem Anstieg der drogenbedingten Todesfälle gegenüber. Im Jahr 2022 waren die drogenbedingten Überdosen nahezu doppelt so hoch wie die Anzahl der Gewaltverbrechen in der Stadt. Die Kampagne zeigt Smith in einem Bildungsvideo mit dem Titel 'Lay, Spray, Stay', das die Anwendung von NARCAN® demonstriert und das in den örtlichen Taxifernsehern in der Stadt ausgestrahlt wird.
Die Initiative fällt mit der Ausrichtung von rund 83.000 Fans für den Big Game in New Orleans zusammen. Hunderte von Kartons NARCAN® Nasal Spray werden an diesem Wochenende in der Stadt verteilt. Ziel der Kampagne ist es, das Stigma rund um unbeabsichtigte Opioidvergiftungen zu reduzieren und die Gemeinden über lebensrettende Maßnahmen aufzuklären.
- None.
- None.
- Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an increase in accidental drug-related deaths year over year
- The ‘Lay, Spray, Stay’ opioid overdose educational video featuring Smith and how to use NARCAN® Nasal Spray will appear on local taxi television screens throughout the city
- Hundreds of NARCAN® Nasal Spray cartons will be given away to people in New Orleans throughout the weekend
GAITHERSBURG, Md., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it is raising awareness of the Ready to Rescue initiative in New Orleans with pro football legend and NARCAN® Nasal Spray spokesperson, Emmitt Smith, as the city welcomes an anticipated 83,000 fans for the Big Game. For the past two years, Smith has traveled the country sharing his personal connection to the opioid epidemic to help reduce the stigma around accidental opioid poisonings and educate communities on how to save a life with NARCAN® Nasal Spray. Now, as New Orleans gears up to host one of the biggest events of the year, Emergent and Smith will continue these efforts to ensure the city is prepared to act in an opioid emergency, which can happen anytime, anywhere and to anyone.
Recent data reported by the Centers for Disease Control and Prevention show a national reduction in opioid overdose deaths for the first time in five years.i Despite this overall decline, there is still more work to be done as many U.S. communities continue to see an increase in accidental drug-related deaths year over year – including New Orleans.ii In fact, in 2022, there were still nearly twice as many drug-related overdose deaths as homicides in New Orleans.iii For these reasons, increased access to education on opioid overdose risks and NARCAN® Nasal Spray is critical.
That’s why Emergent’s public education campaign with Smith explaining how to administer NARCAN® Nasal Spray using three simple steps – Lay, Spray, Stay – will be displayed via taxi television screens throughout the city leading up to Sunday’s game. Smith will also be speaking to national and local media onsite to highlight how this life-saving medication can reverse the effects of an opioid poisoning in minutes and is available over the counter giving everyone the power to save a life.
“All eyes will be on New Orleans this weekend and as part of our ongoing efforts to educate the masses on opioid emergency preparedness, we hope to use this key cultural moment as a way to encourage more conversation about the realities of opioid poisonings and how tools like NARCAN® Nasal Spray can save lives,” said Paul Williams, SVP and products business head, Emergent. “We remain committed to helping to stem the tide of opioid overdose deaths, and believe over the counter access to NARCAN® Nasal Spray and our work with government, advocacy, businesses and retail partners are paramount to keeping communities safer and ready to rescue.”
Learn more about how you can access NARCAN® Nasal Spray and be prepared to save a life at NARCAN.com.
Emmitt Smith is a paid spokesperson for Emergent.
About NARCAN® Nasal Spray
NARCAN® Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose. NARCAN® Nasal Spray is not a substitute for emergency medical care. Repeat dosing may be necessary. Use as directed.
About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For over 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Safe Harbor Statement
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are forward-looking statements. We generally identify forward-looking statements by using words like “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “may,” “plan,” “position,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would,” and similar expressions or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements. Forward-looking statements are based on our current intentions, beliefs and expectations regarding future events based on information that is currently available. We cannot guarantee that any forward-looking statements will be accurate. Readers should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Readers are, therefore, cautioned not to place undue reliance on any forward-looking statements. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, we do not undertake any obligation to update any forward-looking statement to reflect new information, events or circumstances.
There are a number of important factors that could cause the company’s actual results to differ materially from those indicated by any forward-looking statements. Readers should consider this cautionary statement, as well as the risk factors and other disclosures included in our periodic reports filed with the U.S. Securities and Exchange Commission, when evaluating our forward-looking statements.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
i U.S. Overdose Deaths Decrease in 2023, First Time Since 2018
ii 2023 Coroner's Report on Accidental Drug-Related Deaths in New Orleans | Orleans Coroner
iii 2023 Annual Opioid Report
FAQ
What is the Ready to Rescue campaign by EBS featuring Emmitt Smith in New Orleans?
How many NARCAN® Nasal Spray cartons will EBS distribute in New Orleans?
What are the three steps for using NARCAN® Nasal Spray according to EBS's campaign?
How does the 2022 drug overdose rate compare to homicides in New Orleans?
How many fans are expected to attend the Big Game in New Orleans during EBS's campaign?
Where will EBS display their NARCAN® educational video in New Orleans?
